Frontlight ResearchEarly access
Trial site
Instituto Veracruzano en Investigación Clínica S.C.
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- Chronic kidney disease2 trials
- Obesity2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Peripheral artery disease1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Active, not recruiting6 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Pfizer3 trials
- Inversago Pharma Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026